Hasta la próxima

Auto reproducción

Ductal carcinoma in situ, are we over-treating it?

7 vistas • 06/19/23
Compartir
Empotrar
administrator
administrator
Suscriptores
0

Prof Cheng-Har Yip spoke to ecancer at the BGICC 2020 conference in Cairo, Egypt about DCIS (ductal carcinoma in situ).

She describes firstly what DCIS is; a pre-cancerous or non-invasive cancerous lesion of the breast, cl****ified as Stage 0.

Prof Yip explains why and when a mastectomy might be needed, and some of the genomics research currently used to look at which DCIS may progress.

She also outlines what some of the risks and complications can be along these procedures.

Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php

Mostrar más
0 Comentarios sort Ordenar por
Comentarios de Facebook

Hasta la próxima

Auto reproducción